Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 199… Read more
Bio Green Med Solution, Inc. (BGMS) - Total Assets
Latest total assets as of September 2025: $8.16 Million USD
Based on the latest financial reports, Bio Green Med Solution, Inc. (BGMS) holds total assets worth $8.16 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bio Green Med Solution, Inc. - Total Assets Trend (2005–2024)
This chart illustrates how Bio Green Med Solution, Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bio Green Med Solution, Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Bio Green Med Solution, Inc.'s total assets of $8.16 Million consist of 89.7% current assets and 10.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 76.6% |
| Accounts Receivable | $237.00K | 5.8% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2005–2024)
This chart illustrates how Bio Green Med Solution, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bio Green Med Solution, Inc.'s current assets represent 89.7% of total assets in 2024, an increase from 89.3% in 2005.
- Cash Position: Cash and equivalents constituted 76.6% of total assets in 2024, up from 16.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 5.8% of total assets.
Bio Green Med Solution, Inc. Competitors by Total Assets
Key competitors of Bio Green Med Solution, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Bio Green Med Solution, Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Bio Green Med Solution, Inc. generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Bio Green Med Solution, Inc. is currently not profitable relative to its asset base.
Bio Green Med Solution, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.43 | 0.77 | 14.27 |
| Quick Ratio | 5.07 | 0.77 | 14.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.44 Million | $ -1.44 Million | $ 32.98 Million |
Bio Green Med Solution, Inc. - Advanced Valuation Insights
This section examines the relationship between Bio Green Med Solution, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -53.5% |
| Total Assets | $4.09 Million |
| Market Capitalization | $8.61K USD |
Valuation Analysis
Below Book Valuation: The market values Bio Green Med Solution, Inc.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Bio Green Med Solution, Inc.'s assets decreased by 53.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Bio Green Med Solution, Inc. (2005–2024)
The table below shows the annual total assets of Bio Green Med Solution, Inc. from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.09 Million | -53.50% |
| 2023-12-31 | $8.80 Million | -68.61% |
| 2022-12-31 | $28.05 Million | -34.97% |
| 2021-12-31 | $43.14 Million | +17.21% |
| 2020-12-31 | $36.80 Million | +140.41% |
| 2019-12-31 | $15.31 Million | -22.78% |
| 2018-12-31 | $19.82 Million | -23.77% |
| 2017-12-31 | $26.00 Million | +32.25% |
| 2016-12-31 | $19.66 Million | -20.60% |
| 2015-12-31 | $24.76 Million | -15.73% |
| 2014-12-31 | $29.39 Million | -17.27% |
| 2013-12-31 | $35.52 Million | +83.53% |
| 2012-12-31 | $19.35 Million | -25.56% |
| 2011-12-31 | $26.00 Million | -17.36% |
| 2010-12-31 | $31.46 Million | +117.47% |
| 2009-12-31 | $14.47 Million | -53.27% |
| 2008-12-31 | $30.96 Million | -59.22% |
| 2007-12-31 | $75.91 Million | +19.97% |
| 2006-12-31 | $63.28 Million | +231.79% |
| 2005-12-31 | $19.07 Million | -- |